Understand WHO GMP certification, its importance in pharmaceutical exports, and what buyers should verify before choosing a manufacturing partner.
Explore what US buyers should check when choosing pharmaceutical contract manufacturers in India for reliable and compliant US market supply.
See how global pharma buyers pick Indian contract manufacturers for export, and how Caritas Healthcare supports reliable, compliant production.
A practical guide for international buyers on selecting a reliable pharma manufacturing partner in India, backed by Caritas Healthcare's export expertise.
Emerging markets are reshaping the global pharmaceutical landscape. According to IQVIA, emerging markets are projected to account for over 30% of global pharmaceutical spending by 2026, with growth rates consistently outpacing developed markets.
Across developing countries, there is a staggering gap between healthcare needs and available resources. According to the latest WHO-World Bank report, 2 billion people worldwide face financial hardship due to healthcare costs, while the situation in sub-Saharan Africa is particularly acute: the continent imports a significant majority of its pharmaceuticals, leaving it highly vulnerable to global supply chain disruption